AT7867 is primarily used in research settings as a potent inhibitor of protein kinases, particularly targeting AKT and p70 S6 kinase. Its application is significant in studying cellular signaling pathways, especially those involved in cell growth, proliferation, and survival. Researchers utilize AT7867 to investigate the role of these kinases in various diseases, including cancer, where aberrant signaling often contributes to tumor development and progression. By inhibiting these kinases, AT7867 helps in understanding their function and exploring potential therapeutic strategies. Additionally, it is employed in preclinical studies to assess the efficacy of kinase inhibition in reducing tumor growth and improving treatment outcomes. Its role in modulating these pathways makes it a valuable tool in molecular biology and oncology research.